Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Primary Target

NAD-dependent deacetylase sirtuin 3

4

Histamine H1 receptor

316

Dopamine D2 receptor

311

DNA

282

Serotonin 2a (5-HT2a) receptor

237

All Match

Any Match

Exclude Selected

Exclude Selected

Development Status

US Approved Rx

3

Other

1

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

3

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

1947

3

Unknown

1

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Arteriosclerotic syndromes

3

Ophthalmology

3

Pellagra

3

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Preventing

3

Primary

3

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Penetrant

3

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

GenDerm|National Institutes of Health|University of Washington

3

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

4

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

4

EPA CompTox

4

FDA UNII

4

PUBCHEM

4

ECHA (EC/EINECS)

3

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ALIMENTARY TRACT AND METABOLISM

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

VITAMINS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

OTHER PLAIN VITAMIN PREPARATIONS

1

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Other plain vitamin preparations

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

2

Salts, Hydrates, Esters, etc.

2

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 4 of 4 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

NIACINAMIDE

25X51I8RD4

Export Data
Search for Structure

Status:

US Approved Rx (2001)

First approved in 1947

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

NAD-dependent deacetylase sirtuin 2

NAD-dependent deacetylase sirtuin 1

NAD-dependent deacetylase sirtuin 3

Conditions:

Arteriosclerotic syndromes

Niacinamide, known as nicotinamide, is an important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and pellagra. Pellagra is a nutritional disease that occurs due to i...

nsufficient dietary amounts of vitamin B3 or the chemical it is made from (tryptophan). Symptoms of pellagra include skin disease, diarrhea, dementia, and depression. In addition, was experiments, revealed, that niacinamide hydroiodide might have role in ophthalmology and parenteral use of niacinamide hydroiodide can treat arteriosclerotic syndromes.

PETUNIDIN 3-GLUCOSIDE

AA9G36JBHT

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

NAD-dependent deacetylase sirtuin 3

NIACINAMIDE HYDROCHLORIDE

4D16EOF1QW

Export Data
Search for Structure

Status:

US Approved Rx (2001)

First approved in 1947

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

NAD-dependent deacetylase sirtuin 2

NAD-dependent deacetylase sirtuin 1

NAD-dependent deacetylase sirtuin 3

Conditions:

Arteriosclerotic syndromes

Niacinamide, known as nicotinamide, is an important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and pellagra. Pellagra is a nutritional disease that occurs due to i...

nsufficient dietary amounts of vitamin B3 or the chemical it is made from (tryptophan). Symptoms of pellagra include skin disease, diarrhea, dementia, and depression. In addition, was experiments, revealed, that niacinamide hydroiodide might have role in ophthalmology and parenteral use of niacinamide hydroiodide can treat arteriosclerotic syndromes.

NIACINAMIDE HYDRIODIDE

6UNY448CMZ

Export Data
Search for Structure

Status:

US Approved Rx (2001)

First approved in 1947

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

NAD-dependent deacetylase sirtuin 2

NAD-dependent deacetylase sirtuin 1

NAD-dependent deacetylase sirtuin 3

Conditions:

Arteriosclerotic syndromes

Niacinamide, known as nicotinamide, is an important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and pellagra. Pellagra is a nutritional disease that occurs due to i...

nsufficient dietary amounts of vitamin B3 or the chemical it is made from (tryptophan). Symptoms of pellagra include skin disease, diarrhea, dementia, and depression. In addition, was experiments, revealed, that niacinamide hydroiodide might have role in ophthalmology and parenteral use of niacinamide hydroiodide can treat arteriosclerotic syndromes.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1